Literature DB >> 22661293

Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

Selma F Witchel1, Sergio E Recabarren, Frank González, Evanthia Diamanti-Kandarakis, Kai I Cheang, Antoni J Duleba, Richard S Legro, Roy Homburg, Renato Pasquali, Rogerio A Lobo, Christos C Zouboulis, Fahrettin Kelestimur, Franca Fruzzetti, Walter Futterweit, Robert J Norman, David H Abbott.   

Abstract

The interactive nature of the 8th Annual Meeting of the Androgen Excess and PCOS Society Annual Meeting in Munich, Germany (AEPCOS 2010) and subsequent exchanges between speakers led to emerging concepts in PCOS regarding its genesis, metabolic dysfunction, and clinical treatment of inflammation, metabolic dysfunction, anovulation and hirsutism. Transition of care in congenital adrenal hyperplasia from pediatric to adult providers emerged as a potential model for care transition involving PCOS adolescents.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22661293      PMCID： PMC3485440          DOI： 10.1007/s12020-012-9701-4

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


  112 in total

1.  Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

Authors:  Christopher R McCartney; Susan K Blank; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Kristin D Helm; Richard Yoo; R Jeffrey Chang; Carol M Foster; Sonia Caprio; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

2.  Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring.

Authors:  David H Abbott; Cristin R Bruns; Deborah K Barnett; Andrea Dunaif; Theodore L Goodfriend; Daniel A Dumesic; Alice F Tarantal
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-03       Impact factor: 4.310

Review 3.  Polycystic ovary syndrome.

Authors:  S Franks
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

4.  Does laparoscopic ovarian diathermy change clomiphene-resistant PCOS into clomiphene-sensitive?

Authors:  Hatem Abu Hashim; Mohamed El-Shafei; Ahmed Badawy; Alaa Wafa; Hosam Zaglol
Journal:  Arch Gynecol Obstet       Date:  2011-05-19       Impact factor: 2.344

Review 5.  Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.

Authors:  Ricardo Azziz; Catherine Marin; Lalima Hoq; Enkhe Badamgarav; Paul Song
Journal:  J Clin Endocrinol Metab       Date:  2005-06-08       Impact factor: 5.958

6.  Metabolic profile in sons of women with polycystic ovary syndrome.

Authors:  Sergio E Recabarren; Rosita Smith; Rafael Rios; Manuel Maliqueo; Bárbara Echiburú; Ethel Codner; Fernando Cassorla; Pedro Rojas; Teresa Sir-Petermann
Journal:  J Clin Endocrinol Metab       Date:  2008-01-29       Impact factor: 5.958

Review 7.  Congenital adrenal hyperplasia - how to improve the transition from adolescence to adult life.

Authors:  B Kruse; F G Riepe; N Krone; H A G Bosinski; S Kloehn; C J Partsch; W G Sippell; H Mönig
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-07       Impact factor: 2.949

8.  Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).

Authors:  Evanthia Diamanti-Kandarakis; Ilias Katsikis; Christina Piperi; Eleni Kandaraki; Athanasia Piouka; Athanasios G Papavassiliou; Dimitrios Panidis
Journal:  Clin Endocrinol (Oxf)       Date:  2008-03-19       Impact factor: 3.478

9.  State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

Authors:  David H Geller; Danièle Pacaud; Catherine M Gordon; Madhusmita Misra
Journal:  Int J Pediatr Endocrinol       Date:  2011-08-26

10.  Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue.

Authors:  Katerina K Papachroni; Christina Piperi; Georgia Levidou; Penelope Korkolopoulou; Leszek Pawelczyk; Evanthia Diamanti-Kandarakis; Athanasios G Papavassiliou
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310
View more
  13 in total

1.  Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients.

Authors:  Alice Albu; Serban Radian; Simona Fica; Carmen Gabriela Barbu
Journal:  Endocrine       Date:  2014-07-15       Impact factor: 3.633

2.  Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.

Authors:  Sarantis Livadas; Christos Pappas; Athanasios Karachalios; Evangelos Marinakis; Nikoleta Tolia; Maria Drakou; Philippos Kaldrymides; Dimitrios Panidis; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2014-04-22       Impact factor: 3.633

3.  [Pathophysiology of acne. What is confirmed?].

Authors:  C C Zouboulis
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

Review 4.  Episodic hormone secretion: a comparison of the basis of pulsatile secretion of insulin and GnRH.

Authors:  Craig S Nunemaker; Leslie S Satin
Journal:  Endocrine       Date:  2014-03-08       Impact factor: 3.633

Review 5.  Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.

Authors:  Dimitrios Panidis; Konstantinos Tziomalos; Efstathios Papadakis; Christos Vosnakis; Panagiotis Chatzis; Ilias Katsikis
Journal:  Endocrine       Date:  2013-04-27       Impact factor: 3.633

Review 6.  Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility.

Authors:  Georgios Boutzios; Maria Karalaki; Evangelia Zapanti
Journal:  Endocrine       Date:  2012-08-29       Impact factor: 3.633

Review 7.  Gastrointestinal hormones and polycystic ovary syndrome.

Authors:  Jing Ma; Tzu Chun Lin; Wei Liu
Journal:  Endocrine       Date:  2014-05-04       Impact factor: 3.633

8.  Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome.

Authors:  Frank González; Chang Ling Sia; Frank Z Stanczyk; Hilary E Blair; Michelle E Krupa
Journal:  Endocrine       Date:  2012-07-01       Impact factor: 3.633

9.  Developmental programming: exposure to testosterone excess disrupts steroidal and metabolic environment in pregnant sheep.

Authors:  B Abi Salloum; A Veiga-Lopez; D H Abbott; C F Burant; V Padmanabhan
Journal:  Endocrinology       Date:  2015-03-12       Impact factor: 4.736

10.  Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome.

Authors:  Ewa Czeczuga-Semeniuk; Katarzyna Jarząbek; Marzenna Galar; Piotr Kozłowski; Nela A Sarosiek; Gabriela Zapolska; Sławomir Wołczyński
Journal:  Endocrine       Date:  2014-07-11       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.